Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-597-8 | CAS number: 108-59-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Assessment of the toxicokinetik behaviour of test substance (CAS 108 -59 -8):
The test substance (molecular weight of 132.12 g/mol) is a liquid (Ciba-Geigy, 1980) with a log Pow of -0.05 (Gestis, 2011), a water solubility of 99 g/L (OECD SIDS, 2006), and a vapor pressure of 0.15 hPa (Gestis, 2011).
Absorption
From the physico-chemical properties of dimethyl malonate (DMM) it can be assumed that it is readily absorbed via mucous membranes. In a combined repeated dose toxicity study/reproduction and developmental screening test, rats were administered 100, 300, and 1000 mg/kg bw test substance by gavage, respectively. No mortality was reported. Histopathology revealed an increased incidence of hepatocellular hypertrophy in the rats at the 1000 mg/kg bw dose group; therefore bioavailability of the test substance after oral administration is indicated (Degussa Ag, 2003, see chapter “repeated dose toxicity”).
In a Buehler Test, which was performed to detect skin sensitizing properties in guinea pigs, no indications of systemic availability after dermal application was detected (Huels AG, 1992). Although the physical state and molecular weight would favor a dermal uptake, the low log Pow (-0,086) and the high water solubility would prevent the test substance to cross the lipid rich environment of the stratum corneum. Dermal uptake for these substances will be low (ECHA GD 7c, 2008).
The test substance itself has a low vapor pressure of 0.15 hPa at 25°C. Moderate log Pow values (between -1 and 4) are favourable for absorption directly across the respiratory tract epithelium by passive diffusion. Due to the high water solubility of DMM it would be effectively removed from the air in the upper respiratory tract. Therefore, a low potential of toxicity of the substance vapor via the inhalative route is considered.
Metabolism
DMM is likely to be metabolized by unspecific (serine-) esterases of different tissues, in particular in the liver to the mono ester and finally to malonic acid and the corresponding alcohol methanol. This is corroborated by the findings of the abiotic hydrolysis, in particular at alkaline pH that can be regarded as qualitatively similar to the hydrolysis catalyzed by unspecific esterases. The hydrolysis products are likely to be metabolized via physiological pathways as the tricarboxylic acid cycle because they are part of the normal intermediate metabolism.
The mammalian metabolism of methanol, a metabolite of DMM, occurs mainly in the liver, where methanol is converted to formaldehyde, which is in turn converted to formate. Formate is then finally converted to carbon dioxide and water. In humans, the conversion to formaldehyde is mediated by alcohol dehydrogenase. In rodents, the reaction occurs mainly via a catalase-peroxide pathway. In rodents, the first step is rate limiting and methanol in turn accumulates in the blood. In primates, the conversion of formate to carbon dioxide is rate-limiting, leading to a disproportionate increase of formate in the blood and sensitive target tissues (OECD, 2004, ICCA HPV dossier on methanol). Methanol exhibits potential hazardous properties for human health (neurological effects, CNS depression, ocular effects, reproductive and developmental effects, and other organ toxicity). The effects of methanol on the CNS and retina in humans only occur at doses at which formate accumulates due to a rate-limiting conversion to carbon dioxide. In primates, formate accumulatian was observed at methanol doses greater than 500 mg/kg bw. Such high methanol exposures could only be produced from DMM doses of more than 1000 mg/kg bw. As there were no indications of a methanol associated toxicity from a well performed repeated dose toxicity study with DMM in rodents (which are, however, known to be less sensitive to methanol toxicity than humans), and because methanol toxicity would not be expected up to doses as high as 1000 mg DMM/kg bw/day, it was concluded that methanol does not make a relevant contribution to the toxicity profile of DMM. Studies on genotoxicity (Ames-Test, chromosome aberration in-vitro) gave no indications of a reactivity of test substance or its metabolites under the test conditions (i.e. no increased mutagenicity or cytotoxicity in treatments with metabolic activation).
Excretion
The methyl moiety of DMM is converted to carbon dioxide and water, which will be excreted by the lung or urine, respectively. Malonic acid is further metabolized via physiological pathways as the tricarboxylic acid cycle.
References
Institut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung (IFA), GESTIS-Stoffdatenbank,Gefahrstoffinformationssystem der Deutschen Gesetzlichen Unfallversicherung (19.04.2011)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.